Nephrotic Syndrome

Glomerular disorder characterized by massive proteinuria (>3.5 g/24 hours in adults or >40 mg/m²/hour in children), leading to hypoalbuminemia, generalized edema, hyperlipidemia, and lipiduria

Aetiology

Primary (Idiopathic) Glomerular Diseases

  1. Minimal Change Disease (MCD)
      • Most common cause in children
      • Often associated with atopy, infection, or vaccination
  1. Focal Segmental Glomerulosclerosis (FSGS)
      • Most common cause in adults
      • Can be primary or secondary (HIV, obesity, sickle cell disease)
  1. Membranous Nephropathy
      • Common in adults
      • May be idiopathic (anti-PLA2R antibodies) or secondary
  1. Membranoproliferative GN (rarely nephrotic-predominant)

Secondary Causes

  • Diabetes mellitus (diabetic nephropathy)
  • Systemic lupus erythematosus
  • Amyloidosis
  • Infections (HIV, hepatitis B and C)
  • Drugs (NSAIDs, gold)
  • Malignancies (solid tumors, lymphoma)

Pathophysiology

  • Podocyte injury → effacement of foot processes
  • Loss of size and charge selectivity of GBM
  • Massive leakage of plasma proteins, especially albumin
  • Hypoalbuminemia → decreased plasma oncotic pressure
  • Compensatory hepatic synthesis of lipoproteins → hyperlipidemia
  • Sodium and water retention → generalized edema

Clinical presentation

Edema (Cardinal Feature)

  • Generalized (anasarca)
  • Periorbital edema (morning)
  • Peripheral edema
  • Ascites and pleural effusion in severe cases

Urinary Abnormalities

  • Frothy or foamy urine
  • Oliguria (in advanced disease)
  • Lipiduria (fatty casts, oval fat bodies)

Systemic Manifestations

  • Fatigue
  • Weight gain
  • Susceptibility to infections
  • Thromboembolic events (renal vein thrombosis, DVT)
Type
Definition
Steroid-sensitive
Urine protein nil/trace for 3 consecutive days
Steroid-Resistant
No remission ≥4–6 weeks
Steroid-Dependent
Two consecutive relapses during taper/≤14 days
Frequently Relapsing
≥2 relapses/6 mo or ≥4/yr
Infrequently Relapsing
Less frequent relapses

Investigations

Urinalysis

  • Proteinuria >3.5 g/day
  • Fatty casts
  • Oval fat bodies (Maltese cross under polarized light)

Blood Tests

  • Hypoalbuminemia
  • Hyperlipidemia
  • Possible azotemia in advanced disease
  • Reduced immunoglobulins

Serologic and Etiologic Workup

  • ANA, anti-dsDNA
  • Hepatitis B and C serology
  • HIV testing
  • Anti-PLA2R antibodies (membranous nephropathy)

Renal Biopsy

  • Indicated in most adults
  • Often not required in children with suspected MCD

Management

  • Salt restriction
  • Fluid restriction (if significant edema)
  • Corticosteroids
    • Prednisone 2mg/kg/day
  • Diuretics (loop ± thiazide)
    • Furosemide 1-3mg/kg/day
  • ACE inhibitors or ARBs to reduce proteinuria
  • Statins for hyperlipidemia
  • Anticoagulation (selected high-risk patients)
Disease
Specific Treatment
Minimal Change Disease
Corticosteroids
FSGS
Steroids ± calcineurin inhibitors
Membranous nephropathy
Immunosuppression (risk stratified)
Diabetic nephropathy
Glycemic and BP control